全文获取类型
收费全文 | 6024篇 |
免费 | 649篇 |
国内免费 | 4篇 |
专业分类
6677篇 |
出版年
2021年 | 88篇 |
2019年 | 54篇 |
2018年 | 88篇 |
2017年 | 69篇 |
2016年 | 118篇 |
2015年 | 154篇 |
2014年 | 201篇 |
2013年 | 233篇 |
2012年 | 297篇 |
2011年 | 304篇 |
2010年 | 213篇 |
2009年 | 161篇 |
2008年 | 295篇 |
2007年 | 276篇 |
2006年 | 217篇 |
2005年 | 211篇 |
2004年 | 226篇 |
2003年 | 209篇 |
2002年 | 209篇 |
2001年 | 137篇 |
2000年 | 126篇 |
1999年 | 129篇 |
1998年 | 73篇 |
1997年 | 71篇 |
1996年 | 76篇 |
1995年 | 59篇 |
1994年 | 67篇 |
1993年 | 63篇 |
1992年 | 126篇 |
1991年 | 119篇 |
1990年 | 105篇 |
1989年 | 118篇 |
1988年 | 121篇 |
1987年 | 89篇 |
1986年 | 91篇 |
1985年 | 75篇 |
1984年 | 85篇 |
1983年 | 73篇 |
1982年 | 57篇 |
1981年 | 54篇 |
1980年 | 66篇 |
1979年 | 69篇 |
1978年 | 77篇 |
1977年 | 57篇 |
1976年 | 69篇 |
1975年 | 57篇 |
1974年 | 57篇 |
1973年 | 75篇 |
1972年 | 48篇 |
1969年 | 47篇 |
排序方式: 共有6677条查询结果,搜索用时 0 毫秒
1.
2.
3.
DNA damage is a common hazard that all cells have to combat. Saccharomyces cerevisiae HMO2 is a high mobility group protein (HMGB) that is a component of the chromatin-remodeling complex INO80, which is involved in double strand break (DSB) repair. We show here using DNA end-joining and exonuclease protection assays that HMO2 binds preferentially to DNA ends. While HMO2 binds DNA with both blunt and cohesive ends, the sequence of a single stranded overhang significantly affects binding, supporting the conclusion that HMO2 recognizes features at DNA ends. Analysis of the effect of duplex length on the ability of HMO2 to protect DNA from exonucleolytic cleavage suggests that more than one HMO2 must assemble at each DNA end. HMO2 binds supercoiled DNA with higher affinity than linear DNA and has a preference for DNA with lesions such as pairs of tandem mismatches; however, comparison of DNA constructs of increasing length suggests that HMO2 may not bind stably as a monomer to distorted DNA. The remarkable ability of HMO2 to protect DNA from exonucleolytic cleavage, combined with reports that HMO2 arrives early at DNA DSBs, suggests that HMO2 may play a role in DSB repair beyond INO80 recruitment. 相似文献
4.
Enzymes are remarkable molecules which make metabolism possible. Their processing powers are considerable for not only are they catalysts they also contribute to information processing, integration, coherence and memory in the cell. This complex of attributes suggests that a complementary perspective to enzyme nature and activity is needed related to what enzymes and verbs have in common. The value of this kind of thinking is that it shifts the focus from objects and mechanisms to processes and information. In order to support this idea a number of features which enzymes and verbs share are discussed including, context-dependence, occurrence, cases, voice, mood and glue/integrative capacities. The paper concludes with some reflections on the utility of a view of enzymes as verbs. 相似文献
5.
Abstract— l -Tyrosine:2-oxoglutarate aminotransferase (EC 2.6.1.5) activity in rat brain is not regulated in the same way as in rat liver. No diurnal rhythm in the activity of the cerebral enzyme was found in rats fed ad lib. although there was a marked diurnal variation in the activity of the hepatic enzyme. In adrenalectomized rats, hydrocortisone and glucagon induced the enzyme in liver but had no effect on the enzyme in brain. In normal rats, treatment with reserpine or exposure to cold elevated the activity of the hepatic enzyme without affecting the enzyme in brain. Thus, the tyrosine aminotransferase of brain differed from the enzyme in liver since it did not exhibit diurnal variations of activity and was not affected by hormones, drugs, or stress. 相似文献
6.
7.
The build-up of neurosecretory material in the median neurosecretory cells and fibre tracts of cultured cockroach brains was demonstrated by staining and bioassay. Examination of the cultured brains by electron microscopy showed active production of neurosecretory granules after 3 days in vitro. The close correlation of the results obtained by these different methods of assay leaves little doubt that a neurohormone is being synthesized and stored. 相似文献
8.
The biodistribution and pharmacokinetics of vanadium following i.p. administration of vanadocene dichloride (VDC), a representative of a new class of organometallic anticancer agents, is reported for Strain A mice. A convenient flameless atomic absorption spectroscopic assay is described and is used to determine kinetic profiles for vanadium in blood, kidney, liver, small intestine and brain tissue for times up to 24 h after administration. For a VDC dose of 80 mg/kg, vanadium concentration decreases rapidly from both the blood and small intestine, and the data can be fit to a phenomenological exponential function (blood: t1/2 = 118 +/- 43 min; small intestine: t1/2(alpha) = 18.10 +/- 0.14 min, t1/2(beta) = 341 +/- 45 min). In contrast, vanadium accumulates in both the kidney and liver up to a maximal concentration (1.12 +/- 0.06 mM and 0.56 +/- 0.06 mM after 12 and 8 h, respectively), and is then excreted with estimated half-lives of 7.9 +/- 0.7 and 12.1 +/- 0.1 h, respectively. No detectable levels of vanadium are found in the brain tissue over the temporal course of the experiment. These results are compared to previous mammalian studies with cis-dichlorodiammineplatinum(II) (CDDP) and related 'second generation' platinum derivatives; there are both qualitative similarities between the vanadium and platinum systems as well as important quantitative differences. 相似文献
9.
10.